Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,462 | -223,485 | -145,435 | -87,518 | -38,986 |
| Depreciation Amortization | -3,648 | 8,506 | 7,124 | 5,008 | 2,690 |
| Accounts payable and accrued liabilities | 1,789 | 2,896 | -575 | 779 | -1,933 |
| Other Working Capital | 6,772 | 12,737 | 16,037 | 5,432 | 4,394 |
| Other Operating Activity | 7,859 | 28,749 | 17,473 | 9,471 | 6,133 |
| Operating Cash Flow | $-47,690 | $-170,597 | $-105,376 | $-66,828 | $-27,702 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -483,779 | -102,745 | -31,460 | -13,869 | -6,972 |
| PPE Investments | -5,609 | -5,841 | -4,694 | -3,851 | -2,913 |
| Sale Of Investment | 41,287 | 183,171 | 146,691 | 93,551 | 59,551 |
| Investing Cash Flow | $-448,101 | $74,585 | $110,537 | $75,831 | $49,666 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 502 | 856,480 | 205,775 | 108,780 | 107,904 |
| Other Financing Activity | 41,060 | 5,067 | -861 | 52,117 | 3,115 |
| Financing Cash Flow | $41,562 | $861,547 | $204,914 | $160,897 | $111,019 |
| Exchange Rate Effect | 23 | 137 | -659 | -712 | -227 |
| Beginning Cash Position | 835,528 | 69,856 | 69,856 | 69,856 | 69,856 |
| End Cash Position | 381,322 | 835,528 | 279,272 | 239,044 | 202,612 |
| Net Cash Flow | $-454,206 | $765,672 | $209,416 | $169,188 | $132,756 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,690 | -170,597 | -105,376 | -66,828 | -27,702 |
| Capital Expenditure | -5,609 | -5,841 | -4,701 | -3,858 | -2,920 |
| Free Cash Flow | -53,299 | -176,438 | -110,077 | -70,686 | -30,622 |